Recent news on Tolcapone

Parkinson Disease Guidelines Aid Diagnosis, Management  May 9, 2006
...backed by less robust evidence, are the dopamine agonists ropinirole, pramipexole, and pergolide, and another catechol-O-methyltransferase inhibitor, tolcapone ... - Journal of American Medical Association (subscription)





New laboratory approach to treat Parkinson’s  Mar 27, 2006
...(Tasmar, also known as tolcapone, is another COMT inhibitor, but it is now rarely used because it can cause severe or even fatal liver toxicity. ... - LabTechnologist.com



Valeant Pharmaceuticals Receives FDA Approval of Less-Restrictive ...  Feb 22, 2006
NYSE:VRX) todayannounced that the US Food and Drug Administration (FDA) hasapproved less-restrictive labeling for Tasmar (tolcapone), thecompany's COMT ... - Finanzen.net,

International Approvals: Tasmar, Amplimexon, IV Remodulin  Jan 17, 2006
Jan. 17, 2006 — Tolcapone tablets have been reintroduced in the UK market after a 7-year suspension by the European Medicines Evaluation Agency; the European ... - Medscape (subscription)

Association of COMT Val158Met Genotype With Executive Functioning ...  Jan 23, 2006
...with Parkinson’s disease have shown improvement on a number of neuropsychological measures during treatment with a selective inhibitor of COMT, Tolcapone. ... - Journal of Neuropsychiatry (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional